Proposed cutoff for identifying adult smokeless tobacco users with urinary total 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanonol: An aggregated analysis of NHANES 2007-2010 data

Nicotine and Tobacco Research

Volumn 15, Issue 11, 2013, Pages 1956-1961

  Agaku, Israel T ^a   Vardavas, Constantine I ^a   Connolly, Gregory ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONOL; BIOLOGICAL MARKER; NITROSAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; GROUPS BY AGE; HUMAN; MALE; MARRIAGE; PASSIVE SMOKING; POVERTY; PRIORITY JOURNAL; RACE DIFFERENCE; SENSITIVITY AND SPECIFICITY; SMOKELESS TOBACCO; SMOKING; YOUDEN INDEX;

EID: 84885168510     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntt083     Document Type: Article

References (24)

1. Benowitz, N. L., Hukkanen, J., & Jacob, P., III. (2009). Nicotine chemistry, metabolism, kinetics and biomarkers. Handbook of Experimental Pharmacology, 192, 29-60. doi:10.1007/978-3-540- 69248-5_2; 10.1007/978-3-540-69248-5_2
2. Bernert, J. T., Pirkle, J. L., Xia, Y., Jain, R. B., Ashley, D. L., & Sampson, E. J. (2010). Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure. Cancer Epidemiology, Biomarkers & Prevention, 19, 2969-2977. doi:10.1158/1055-9965.EPI-10-0711
3. Bhattacharyya, N. (2012). Trends in the use of smokeless tobacco in United States, 2000-2010. The Laryngoscope, 122, 2175-2178.doi:10.1002/lary.23448
4. Carmella, S. G., Chen, M., Han, S., Briggs, A., Jensen, J., Hatsukami, D. K., & Hecht, S. S. (2009). Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chemical Research in Toxicology, 22, 734-741. doi:10.1021/tx800479s
5. Carpenter, C. M., Connolly, G. N., Ayo-Yusuf, O. A., & Wayne, G. F. (2009). Developing smokeless tobacco products for smokers: An examination of tobacco industry documents. Tobacco Control, 18, 54-59. doi:10.1136/tc.2008. 026583
6. Centers for Disease Control and Prevention. (2007). National Center for Health Statistics (NCHS). National Health and Nutrition Examination survey data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/ nhanes/nhanes2007-2008/nhanes07_08.htm
7. Connolly, G. N., & Alpert, H. R. (2008). Trends in the use of cigarettes and other tobacco products, 2000-2007. Journal of the American Medical Association, 299, 2629-2630. doi:10.1001/jama.299.22.2629
8. Curry, L. E., Pederson, L. L., & Stryker, J. E. (2011). The changing marketing of smokeless tobacco in magazine advertisements. Nicotine & Tobacco Research, 13, 540-547. doi:10.1093/ntr/ntr038
9. Goniewicz, M. L., Eisner, M. D., Lazcano-Ponce, E., Zielinska-Danch, W., Koszowski, B., Sobczak, A., . Benowitz, N. L. (2011). Comparison of urine cotinine and the tobaccospecific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking. Nicotine & Tobacco Research, 13, 202-208.doi:10.1093/ntr/ntq237
10. Hatsukami, D. K., Lemmonds, C., Zhang, Y., Murphy, S. E., Le, C., Carmella, S. G., & Hecht, S. S. (2004). Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. Journal of the National Cancer Institute, 96, 844-852.
11. Haufroid, V., & Lison, D. (1998). Urinary cotinine as a tobaccosmoke exposure index: a minireview. International Archives of Occupational and Environmental Health, 71, 162-168.
12. Hecht, S. S., Carmella, S. G., Murphy, S. E., Riley, W. T., Le, C., Luo, X., . Hatsukami, D. K. (2007a). Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiology, Biomarkers & Prevention, 16, 1567-1572. doi:10.1158/1055-9965. EPI-07-0227
13. Hecht, S. S., Carmella, S. G., Murphy, S. E., Riley, W. T., Le, C., Luo, X., . Hatsukami, D. K. (2007b). Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiology, Biomarkers & Prevention, 16, 1567-1572. doi:10.1158/1055-9965. EPI-07-0227
14. Hecht, S. S., Carmella, S. G., Stepanov, I., Jensen, J., Anderson, A., & Hatsukami, D. K. (2008). Metabolism of the tobaccospecific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Cancer Epidemiology, Biomarkers & Prevention, 17, 732-735. doi:10.1158/1055-9965.EPI-07-2843
15. Hecht, S. S., Carmella, S. G., Ye, M., Le, K. A., Jensen, J. A., Zimmerman, C. L., & Hatsukami, D. K. (2002). Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Research, 62, 129-134.
16. Jarvis, M. J., Russell, M. A., Benowitz, N. L., & Feyerabend, C. (1988). Elimination of cotinine from body fluids: Implications for noninvasive measurement of tobacco smoke exposure. American Journal of Public Health, 78, 696-698.
17. Kim, S., & Jung, A. (2013). Optimum cutoff value of urinary cotinine distinguishing south korean adult smokers from nonsmokers using data from the KNHANES (2008-2010). Nicotine & Tobacco Research. Advance online publication. doi:10.1093/ntr/ntt027
18. Kresty, L. A., Carmella, S. G., Borukhova, A., Akerkar, S. A., Gopalakrishnan, R., Harris, R. E.,. . Hechst, S. S. (1996). Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. Cancer Epidemiology, Biomarkers & Prevention, 5, 521-525.
19. Sexton, K., Ryan, A. D., Adgate, J. L., Barr, D. B., & Needham, L. L. (2011). Biomarker measurements of concurrent exposure to multiple environmental chemicals and chemical classes in children. Journal of Toxicology and Environmental Health. Part A, 74, 927-942.doi:10.1080/1 5287394.2011.573745
20. Stanfill, S. B., Connolly, G. N., Zhang, L., Jia, L. T., Henningfield, J. E., Richter, P., . Watson, C. H. (2011). Global surveillance of oral tobacco products: Total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tobacco Control, 20, e2. doi:10.1136/ tc.2010.037465
21. Timberlake, D. S., & Huh, J. (2009). Demographic profiles of smokeless tobacco users in the U.S. American Journal of Preventive Medicine, 37, 29-34. doi:10.1016/ j.amepre.2009.03.010
22. United States Census Bureau. (1995). Definitions. Retrieved from http://www.census.gov/hhes/www/poverty/methods/ definitions.html
23. Upadhyaya, P., Carmella, S. G., Guengerich, F. P., & Hecht, S. S. (2000). Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues. Carcinogenesis, 21, 1233-1238.
24. U.S. Department of Health and Human Services. How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, CDC (2010). Retrieved December 10, 2012, from http://www.cdc.gov/tobacco/data_statistics/sgr/2010/index.htm.